Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Principal Investigator: Samuel Nurko, MD, MPH
Protocol Status: Open for recruitment
Trial Description: Eosinophilic esophagitis (EE) is an inflammatory disease of the esophagus, leading to swallowing problems, pain, food intolerance, and poor weight gain or weight loss in otherwise healthy infants and children. Currently, the only way doctors have to detect and monitor disease activity in patients with EE is by doing an upper endoscopy. This means that patients with EE will typically undergo three to four endoscopies per year. The objective of this study is to develop a laboratory test for EE, so that patients with EE will not need to undergo repeated procedures to monitor the course of their disease.
Recruitment Info: Children between the ages of 1 and 18 years who receive an esophagogastroduodenoscopy (EGD) to evaluate symptoms of esophagitis may be eligible for this study. The study involves the collection of blood, urine, and saliva samples, as well as gastric juice and two esophageal biopsies. The collection of these samples occurs while the patient is under sedation or general anesthesia. Compensation includes a $25 gift card and a parking voucher.
Recruitment Contact: Katharine Rooney
Recruitment Contact Phone: (617) 355-5998
Recruitment Contact Email: Katharine.Rooney@childrens.harvard.edu
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”